Duloxetine enhances PAX6 expression and suppresses innate immune responses in murine LPS-induced corneal inflammation
-
Published:2024-10
Issue:
Volume:34
Page:225-234
-
ISSN:1542-0124
-
Container-title:The Ocular Surface
-
language:en
-
Short-container-title:The Ocular Surface
Author:
Moustardas PetrosORCID,
Abbasi Mojdeh,
Javidjam Dina,
Asamoah Cindy Saah,
Schweitzer-Chaput Arnaud,
Cisternino Salvatore,
Bremond-Gignac Dominique,
Aberdam Daniel,
Lagali NeilORCID
Reference60 articles.
1. Pathophysiology of aniridia-associated keratopathy: developmental aspects and unanswered questions;Latta;Ocul Surf,2021
2. Daruich A, Duncan M, Robert MP, Lagali N, Semina EV, Aberdam D, Ferrari S, Romano V, des Roziers CB, Benkortebi R, De Vergnes N, Polak M, Chiambaretta F, Nischal KK, Behar-Cohen F, Valleix S, Bremond-Gignac D. Congenital aniridia beyond black eyes: From phenotype and novel genetic mechanisms to innovative therapeutic approaches. Prog Retin Eye Res. 2023 Jul;95:101133. doi: 10.1016/j.preteyeres.2022.101133. Epub 2022 Oct 22. PMID: 36280537; PMCID: PMC11062406.
3. The spectrum of PAX6 mutations and genotype-phenotype correlations in the eye;Lima Cunha;Genes,2019
4. Congenital aniridia beyond black eyes: from phenotype and novel genetic mechanisms to innovative therapeutic approaches;Daruich;Prog Retin Eye Res,2023
5. Early phenotypic features of aniridia-associated keratopathy and association with PAX6 coding mutations;Lagali;Ocul Surf,2020